MAP2K1 and Dorfman-Chanarin disease: In summary, pretreatment with NBO and MEK1/2 inhibitor U0126 combined efficiently reduced the incidence of DCS and alleviated DCS spinal cord injury via the antioxidative, anti-inflammatory, and anti-apoptotic effects by HSP32 upregulation in the spinal cord.